Related references
Note: Only part of the references are listed.Somatic Chromosome Abnormalities in the Lungs of Patients with Pulmonary Arterial Hypertension
Micheala A. Aldred et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Dynamic Changes in Lung MicroRNA Profiles During the Development of Pulmonary Hypertension due to Chronic Hypoxia and Monocrotaline
Paola Caruso et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis
Gang Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Smad Proteins Bind a Conserved RNA Sequence to Promote MicroRNA Maturation by Drosha
Brandi N. Davis et al.
MOLECULAR CELL (2010)
TGFβ-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3
B. Wang et al.
ONCOGENE (2010)
miR-21 as a key regulator of oncogenic processes
S. Duygu Selcuklu et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
Altered Bone Morphogenetic Protein and Transforming Growth Factor-β Signaling in Rat Models of Pulmonary Hypertension Potential for Activin Receptor-Like Kinase-5 Inhibition in Prevention and Progression of Disease
Lu Long et al.
CIRCULATION (2009)
Activation of the Bone Morphogenetic Protein Receptor by H11Kinase/Hsp22 Promotes Cardiac Cell Growth and Survival
Xiangzhen Sui et al.
CIRCULATION RESEARCH (2009)
Defective pulmonary vascular remodeling in Smad8 mutant mice
Zheng Huang et al.
HUMAN MOLECULAR GENETICS (2009)
Penetrance of Pulmonary Arterial Hypertension Is Modulated by the Expression of Normal BMPR2 Allele
Rizwan Hamid et al.
HUMAN MUTATION (2009)
Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial Cells
Paul D. Upton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
miR-21: a small multi-faceted RNA
Anna M. Krichevsky et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension
M. Shintani et al.
JOURNAL OF MEDICAL GENETICS (2009)
Updated Clinical Classification of Pulmonary Hypertension
Gerald Simonneau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension
Kewal Asosingh et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
High levels of hyaluronan in idiopathic pulmonary arterial hypertension
Metin Aytekin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Functional redundancy of TGF-beta family type receptors and receptor-smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse
G. D. Orvis et al.
BIOLOGY OF REPRODUCTION (2008)
Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension
M. Talat Nasim et al.
HUMAN MOLECULAR GENETICS (2008)
SMAD proteins control DROSHA-mediated microRNA maturation
Brandi N. Davis et al.
NATURE (2008)
Early-life pulmonary arterial hypertension with subsequent development of diffuse pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia type 1
C. J. Mache et al.
THORAX (2008)
Smad Signaling in the Rat Model of Monocrotaline Pulmonary Hypertension
Margaret F. Ramos et al.
TOXICOLOGIC PATHOLOGY (2008)
Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension
Fares A. Masri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension
Rory E. Morty et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Alterations of cellular bioenergetics in pulmonary artery endothelial cells
Weiling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension
H Takahashi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Mutations of the TGF-β type II receptor BMPR2 in pulmonary arterial hypertension
RD Machado et al.
HUMAN MUTATION (2006)
BMPR2 Gene Rearrangements Account for a Significant Proportion of Mutations in Familial and Idiopathic Pulmonary Arterial Hypertension
Micheala A. Aldred et al.
HUMAN MUTATION (2006)
Dysfunctional smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension
XD Yang et al.
CIRCULATION RESEARCH (2005)
Transforming growth factor-β receptor mutations and pulmonary arterial hypertension in childhood
RE Harrison et al.
CIRCULATION (2005)
Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor
C Atkinson et al.
CIRCULATION (2002)
Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion
RJ Lechleider et al.
DEVELOPMENTAL BIOLOGY (2001)
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
RC Trembath et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene
ZM Deng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension
KB Lane et al.
NATURE GENETICS (2000)
Share Paper
